Einstein Experts for Media

Search Results

You searched for "clinical trials"

6 results found

Nir Barzilai, M.D.

Nir Barzilai, M.D.

Professor, Medicine (Endocrinology)

Director, Institute for Aging Research

Director, Nathan Shock Center of Excellence in the Basic Biology of Aging

Ingeborg and Ira Leon Rennert Chair of Aging Research

AgingBiology of agingLongevity genes

Dr. Barzilai discovered the first “longevity gene” in humans. His research established that the gene variant that leads to high HDL, or “good cholesterol,” is linked to healthy aging and extreme longevity. Dr. Barzilai has been profiled by major outlets, including The New York Times, PBS’ “NOVA scienceNow” and National Geographic. read more...


Jill P. Crandall, M.D.

Jill P. Crandall, M.D.

Professor, Clinical Medicine (Endocrinology), Einstein

Director, Diabetes Clinical Trials Unit, Einstein

Attending Physician, Endocrinology, Montefiore Health System

DiabetesType 2 diabetesDiabetes prevention

Clinical TrialsPrediabetesResveratrol

An expert in diabetes prevention, Dr. Crandall is a principal investigator in the NIH-funded Diabetes Prevention Program Outcomes Study, which showed that sustaining weight loss or taking an anti-diabetic drug can stave off type 2 diabetes in people at high risk for the disease. The American Diabetes Association recently funded Dr. Crandall to study whether the wine ingredient resveratrol can prevent diabetes in patients with prediabetes. read more...


Steven K. Libutti, M.D.

Steven K. Libutti, M.D.

Professor and Vice-Chair, Surgery, Einstein and Montefiore Health System

Professor, Genetics, Einstein

Director, Montefiore Einstein Center for Cancer Care

Associate Director, Clinical Services, Albert Einstein Cancer Center

Cancer surgeryEndocrine surgeryGene therapy

Dr. Libutti is an expert in surgical oncology and endocrine surgery and a pioneer in tumor targeted gene therapy.  His laboratory studies tumors – particularly those of the pancreas, thyroid and adrenal glands – that trigger the formation of new blood vessels that allow tumors to grow and spread.  A holder of five U.S. patents, he is developing novel cancer therapies by studying the complex interactions that occur within the tumor microenvironment.  read more...


Robert E. Michler, M.D.

Robert E. Michler, M.D.

Professor and Chair, Surgery, Einstein and Montefiore Health System

Professor and Chair, Cardiovascular and Thoracic Surgery, Einstein and Montefiore

Co-Director, Montefiore Einstein Center for Heart and Vascular Care

Surgeon-in-Chief, Montefiore

Cardiac surgeryMitral repair surgeryAortic valve surgery Minimally invasive heart surgeryHeart transplantation

Dr. Michler is a heart surgeon who specializes in complex aortic and mitral valve repair surgery. He is an NIH-funded investigator whose interest in repairing the injured heart has led to clinical trials in cardiac stem cell transplantation. Dr. Michler and his teams have advanced minimally invasive cardiothoracic surgery procedures and surgical robotics. This work led to FDA approval for selective cardiac robotic procedures including mitral valve repair and coronary bypass surgery. read more...


Vern L. Schramm, Ph.D.

Vern L. Schramm, Ph.D.

Professor, Biochemistry

Ruth Merns Chair in Biochemistry

BiochemistryEnzymesTranslational medicine

RicinAutoimmune diseases

Dr. Schramm is a member of the National Academy of Sciences and associate editor of the Journal of the American Chemical Society.  His pioneering work in biochemistry has resulted in powerful new strategies for treating cancer, antibiotic resistance and autoimmune diseases. read more...


Joseph A. Sparano, M.D.

Joseph A. Sparano, M.D.

Professor, Medicine (Oncology)

Professor, Obstetrics & Gynecology and Women's Health

Associate Director, Clinical Research, Albert Einstein Cancer Center

Associate Chairman, Medical Oncology, Montefiore Einstein Center for Cancer Care

Breast cancerClinical TrialsHIV-associated cancers

Dr. Sparano is a clinical researcher who develops and evaluates new treatment approaches for  breast cancer, lymphoma, and other cancers, including cancers associated with HIV infection. He also identifies genes that can be used to determine breast cancer prognosis and predict response to treatment – and that may be targeted in cancer as a treatment. He was involved in developing the Oncotype DCIS test, which provides patients with ductal carcinoma in situ of the breast a score that predicts the likelihood of recurrence after surgery, allowing the treatment program to be individualized. read more...